EW

爱德华生命科学
NYSE

实时行情|Nasdaq Last Sale

230.55
+4.01
+1.77%
盘后: 230.50 -0.05 -0.02% 18:16 02/14 EST
开盘
228.27
昨收
226.54
最高
230.77
最低
227.03
成交量
67.97万
成交额
--
52周最高
247.64
52周最低
165.69
市值
480.70亿
市盈率(TTM)
59.66
分时
5日
1月
3月
1年
5年

分析师评级

23位分析师的综合评级

买入

免责声明:分析师观点仅供投资者决策参考,不构成任何买卖投资建议。

EPS

EW 新闻

  • Another Possible Source Of Alpha
  • Seeking Alpha - Article.3天前
  • Benzinga's Top Upgrades, Downgrades For February 13, 2020
  • Benzinga.4天前
  • Goldman likes Intuitive Surgical in premarket analyst action
  • Seeking Alpha - Article.4天前
  • Goldman Sachs Initiates Coverage On Edwards Lifesciences with Neutral Rating, Announces $253 Price Target
  • Benzinga.4天前

更多

所属板块

先进医疗设备和技术
+0.96%
医疗设备和用品
+1.16%

热门股票

名称
价格
涨跌幅

EW 简况

Edwards Lifesciences Corporation is a manufacturer of heart valve systems and repair products used to replace or repair a patient's diseased or defective heart valve. The Company is engaged in patient-focused innovations for structural heart disease and critical care monitoring. Its segments include United States, Europe, Japan and Rest of World. Its products are categorized into three areas: Transcatheter Heart Valve Therapy, Surgical Heart Valve Therapy and Critical Care. It also develops hemodynamic monitoring systems that are used to measure a patient's cardiovascular function in the hospital setting. It is developing products, such as the Edwards SAPIEN 3 Ultra System and Edwards SAPIEN XT transcatheter heart valve, among others. Its Transcatheter Heart Valve Therapy and Surgical Heart Valve Therapy products are manufactured in the United States, Singapore and Switzerland. Critical Care products are manufactured in its facilities located in Puerto Rico and the Dominican Republic.
展开

Webull提供Edwards Lifesciences Corp的股票价格,实时市场报价,专业分析师评级,深度图表和免费的股票新闻,以帮助您做出投资决策。